RJA
MED icon

Raymond James & Associates’s Medifast MED Stock Holding History

Raymond James & Associates’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,021
Closed -$209K – 3918
2023
Q1 		$209K Buy
+2,021
New +$224K ﹤0.01% 3469
2022
Q4 		– Sell
-8,895
Closed -$964K – 4004
2022
Q3 		$964K Sell
8,895
-10,222
-53% -$1.46M ﹤0.01% 2415
2022
Q2 		$3.45M Buy
19,117
+4,567
+31% +$817K ﹤0.01% 1653
2022
Q1 		$2.48M Buy
14,550
+11,843
+437% +$2.23M ﹤0.01% 1978
2021
Q4 		$567K Sell
2,707
-944
-26% -$195K ﹤0.01% 2992
2021
Q3 		$703K Buy
3,651
+2,779
+319% +$683K ﹤0.01% 2815
2021
Q2 		$247K Sell
872
-1,864
-68% -$505K ﹤0.01% 3563
2021
Q1 		$580K Buy
2,736
+373
+16% +$89.3K ﹤0.01% 2908
2020
Q4 		$464K Sell
2,363
-4,054
-63% -$716K ﹤0.01% 2865
2020
Q3 		$1.05M Sell
6,417
-916
-12% -$151K ﹤0.01% 2145
2020
Q2 		$1.02M Buy
7,333
+324
+5% +$29.7K ﹤0.01% 2151
2020
Q1 		$438K Sell
7,009
-470
-6% -$42.8K ﹤0.01% 2503
2019
Q4 		$820K Buy
7,479
+2,345
+46% +$227K ﹤0.01% 2397
2019
Q3 		$532K Buy
+5,134
New +$552K ﹤0.01% 2609
2018
Q4 		– Sell
-2,739
Closed -$607K – 3638
2018
Q3 		$607K Buy
2,739
+170
+7% +$34.5K ﹤0.01% 2576
2018
Q2 		$411K Buy
2,569
+300
+13% +$38.4K ﹤0.01% 2817
2018
Q1 		$212K Buy
+2,269
New +$170K ﹤0.01% 3103

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Raymond James & Associates's MED Position: Q2 2023 in Review

Raymond James & Associates sold out of Medifast (MED) in Q2 2023, closing a stake of 2,021 shares — an estimated $209K sold.

Raymond James & Associates first reported a position in MED in Q1 2018 and held it in 17 quarters. The position peaked at $3.45M in Q2 2022. 236 funds tracked by Wall St. Rank hold MED as of Q2 2023.

  • Raymond James & Associates reported no remaining Medifast position as of Q2 2023 after selling out during the quarter.
  • Raymond James & Associates sold 2,021 Medifast shares in Q2 2023, an estimated $209K.
  • Raymond James & Associates first reported a position in Medifast in Q1 2018 and held it in 17 quarters.
  • Raymond James & Associates's Medifast position peaked at $3.45M in Q2 2022.
  • 236 funds tracked by Wall St. Rank held Medifast as of Q2 2023.

Based on Raymond James & Associates's 13F filing for Q2 2023, filed 25 Jul 2023.